78 related articles for article (PubMed ID: 9036311)
1. Enoxaparin as prophylaxis against thromboembolism after total hip replacement.
Pedell L
N Engl J Med; 1997 Feb; 336(8):585; author reply 586. PubMed ID: 9036311
[No Abstract] [Full Text] [Related]
2. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
3. Enoxaparin as prophylaxis against thromboembolism after total hip replacement.
Anderson DR; Gross M; Robinson KS; Wells PS
N Engl J Med; 1997 Feb; 336(8):585; author reply 586. PubMed ID: 9036310
[No Abstract] [Full Text] [Related]
4. Warfarin vs enoxaparin for deep venous thrombosis prophylaxis after total hip & total knee arthroplasty: a cost comparison.
Garcia-Zozaya I
J Ky Med Assoc; 1998 Apr; 96(4):143-8. PubMed ID: 9577110
[TBL] [Abstract][Full Text] [Related]
5. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
Sarasin FP; Bounameaux H
Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
[TBL] [Abstract][Full Text] [Related]
6. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
Enyart JJ; Jones RJ
Ann Pharmacother; 2005 Jun; 39(6):1002-7. PubMed ID: 15886295
[TBL] [Abstract][Full Text] [Related]
7. Cost analyses of extended prophylaxis with enoxaparin after hip arthroplasty.
Friedman RJ; Dunsworth GA
Clin Orthop Relat Res; 2000 Jan; (370):171-82. PubMed ID: 10660711
[TBL] [Abstract][Full Text] [Related]
8. An unexpected complication of DVT prophylaxis.
Manktelow AR; Haddad FS; Powles DP
Acta Orthop Belg; 1997 Jun; 63(2):134-5. PubMed ID: 9265802
[TBL] [Abstract][Full Text] [Related]
9. [Enoxaparin (clexane) in the prevention of thromboembolism after total hip replacement].
Babiak I; Jabłoński T; Serafin J
Chir Narzadow Ruchu Ortop Pol; 1993; 58(2):14-7. PubMed ID: 7671674
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous enoxaparin for outpatient anticoagulation therapy in a patient with an aortic valve replacement.
Manley HJ; Smith JA; Garris RE
Pharmacotherapy; 1998; 18(2):408-12. PubMed ID: 9545164
[TBL] [Abstract][Full Text] [Related]
11. Warfarin prophylaxis after total knee arthroplasty.
Lieberman JR
Am J Knee Surg; 1999; 12(1):49-53. PubMed ID: 10050694
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a US perspective.
de Lissovoy G; Subedi P
Am J Manag Care; 2002 Dec; 8(12):1082-8. PubMed ID: 12500884
[TBL] [Abstract][Full Text] [Related]
13. A bioavailability study in the proposed patient population--with much more needed now.
Freedman MD
Crit Care Med; 2003 May; 31(5):1588-9. PubMed ID: 12771643
[No Abstract] [Full Text] [Related]
14. The post-discharge prophylactic management of the orthopedic patient with low-molecular-weight heparin: enoxaparin.
Nilsson PE; Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlund U; Nicolas S; Nylander G
Orthopedics; 1997 Feb; 20 Suppl():22-5. PubMed ID: 9048404
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill?
Priglinger U; Delle Karth G; Geppert A; Joukhadar C; Graf S; Berger R; Hülsmann M; Spitzauer S; Pabinger I; Heinz G
Crit Care Med; 2003 May; 31(5):1405-9. PubMed ID: 12771610
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG
Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296
[TBL] [Abstract][Full Text] [Related]
17. Prevention of venous thromboembolism in the rehabilitation phase after spinal cord injury: prophylaxis with low-dose heparin or enoxaparin.
Spinal Cord Injury Thromboprophylaxis Investigators
J Trauma; 2003 Jun; 54(6):1111-5. PubMed ID: 12813331
[TBL] [Abstract][Full Text] [Related]
18. [The cost-effectiveness of fondaparinux compared to enoxaparin as prophylaxis for deep-vein thrombosis in Denmark].
Olsen J; Gundgaard J; Borris LC
Ugeskr Laeger; 2005 May; 167(21):2273-9. PubMed ID: 15962854
[No Abstract] [Full Text] [Related]
19. The prophylaxis of medical patients for thromboembolism pilot study.
Lederle FA; Sacks JM; Fiore L; Landefeld CS; Steinberg N; Peters RW; Eid AA; Sebastian J; Stasek JE; Fye CL
Am J Med; 2006 Jan; 119(1):54-9. PubMed ID: 16431185
[TBL] [Abstract][Full Text] [Related]
20. The post-hospital discharge venous thrombosis risk of the orthopedic patient.
Planes A; Vochelle N
Orthopedics; 1997 Feb; 20 Suppl():18-21. PubMed ID: 9048403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
